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Abstract The P2X7 receptor (P2X7R) is important in medi-
ating a range of physiological functions and pathologies asso-
ciated with tissue damage and inflammation and represents an
attractive therapeutic target. However, in terms of their
structure-function relationships, the mammalian P2X7Rs re-
main poorly characterised compared to some of their other
P2XR counterparts. In this study, combining cysteine-based
cross-linking and whole-cell patch-clamp recording, we ex-
amined six pairs of residues (A44/I331, D48/I331, I58/F311,
S60/L320, I75/P177 and K81/V304) located in different parts
of the extracellular and transmembrane domains of the human
P2X7R. These residues are predicted to undergo substantial
movement during the transition of the receptor ion channel
from the closed to the open state, predictions which are made
based on structural homologymodels generated from the crys-
tal structures of the zebrafish P2X4R. Our results provide
evidence that among the six pairs of cysteine mutants,
D48C/I133C and K81C/V304C formed disulphide bonds that
impaired the channel gating to support the notion that such
conformational changes, particularly those in the outer ends of
the transmembrane domains, are critical for human P2X7R
activation.
Keywords P2X7 receptor . Ion channel gating . Cysteine
substitution . Disulphide bond . Cross linking
Introduction
P2X receptors (P2XR) are a structurally distinctive family of
ligand-gated ion channels activated upon extracellular ATP
binding, which are expressed in many cell types and play a
role in a wide range of physiological functions [1–4]. These
receptors are homo/hetero-trimers assembled from seven
P2XR subunits (P2X1-7), which share a common structural
arrangement comprising intracellular N- and C-termini and
two transmembrane domains (TM1 and TM2) joined by a
large extracellular domain. The crystal structure of the
zebrafish P2X4 receptor (zfP2X4R) subunits with truncated
N- and C-termini has been likened to the shape of a dolphin;
the large extracellular domain constitutes the main body
which is composed of the head, upper body, lower body, dor-
sal fin, left flipper and right flipper, and the two α-helical TM
domains form the tail [5, 6]. The zfP2X4R structures in the
closed and ATP-bound, open states provide the first structural
insights into the non-conventional ATP-binding site and ion
channel gating, in strong agreement with the results from site-
directed mutagenesis studies of the mammalian P2XRs [3, 7].
Furthermore, the zfP2X4R structures have revealed extensive
intra-subunit and inter-subunit interactions and considerable
conformational changes within several parts, most noticeably
the head and lower body of the extracellular domain and the
two TM domains, during receptor activation [6].
The P2X7R, whilst exhibiting strong sequence similarity to
other members of the P2X family and the conservation of key
residues coordinating ATP binding, has unusual functional
properties [8]. For example, P2X7R activation requires sub-
millimolar concentrations of ATP, which is 10–100 times
higher than that required for activation of the other P2XRs
[9]. Activation of the P2X7R exclusively by high concentra-
tions of ATP, which is found at the site of tissue damage or
inflammation, renders the P2X7R to be considered as a
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‘danger sensor’ [10]. It has been well documented that the
P2X7R plays a critical role in both physiological responses
to tissue damage and inflammation and the pathogenesis and
progression of a diversity of associated conditions, including
neuropathic and inflammatory pain, inflammatory diseases
and cancers [11–15]. Evidently, detailed structural delineation
of the P2X7R activation mechanism is important to better
understand P2X7R-dependent physiological functions and
diseases and also for the development of therapeutics targeting
the human P2X7R (hP2X7R). Cysteine-based cross-linking,
in combination with biochemical and functional assays, is a
powerful approach to interrogate the interactions or relative
movements between two adjacent parts of the same protein or
between two neighbouring proteins [8]. This technique has
been successfully applied in previous studies of ion channel
gating (e.g. P2X2R [16], GABAAR [17] and KV [18]), subunit
stoichiometry of the P2X2/3R [19] and the inter-subunit ATP-
binding site in the P2XR [20, 21] and in recent studies of
agonist-induced conformational changes in the P2X1R [22],
P2X2R [23] and P2X3R [24]. Here, we used this approach to
examine conformational changes in the extracellular and
transmembrane domains that are predicted, based on the struc-
tural models, to occur during the hP2X7R activation.
Methods
Homology modelling Structural models of the hP2X7R were
produced based on the structure of the zfP2X4R in the closed
and ATP-bound open states (Protein Data Bank code 4DW0
and 4DW1, respectively) using Modeller version 9.12 [25]
and analysed using MolProbity [26] as described in our pre-
vious studies [27, 28]. The non-conserved loop region be-
tween the β2 and β3 strands was modelled de novo using
the ModLoop server [29]. These models are available from
the authors on request. Thewild-type (WT) hP2X7R sequence
contained residues H155, R270 and A348.
Site-directed mutagenesis Single and double cysteine muta-
tions were introduced into the plasmid encoding the hP2X7R
using a PCR-based site-directed mutagenesis method [30]. In
brief, the PCR sample of 50 μl contained 300 nM of each
primer, 200 μM dNTP mix, 100 ng cDNA and 2.5 U
PfuUltra DNA polymerase (Agilent). PCR consisted of the
following steps: 96 °C for 60 s, 18 cycles consisting of
96 °C for 50 s, 60 °C for 50 s, 68 °C for 14 min and a final
step of 68 °C for 30 min. The PCR product, after treatment
with DpnI (Thermo Fisher Scientific) for 60 min, was trans-
formed into competent E. coli cells (Stratagene). Small-scale
isolation of plasmid was performed using a mini-DNA prep-
aration kit (QIAGEN). Mutations were confirmed by com-
mercial sequencing (Beckman Coulter Genomics).
Cell culture and transient transfection Human embryonic
kidney (HEK) 293 cells were cultured in Dulbecco’sModified
EagleMedium supplemented with 10% foetal bovine serum at
37 °C and 5% CO2, under humidified conditions. Cells were
seeded in 6-well plates at 70–80% confluency prior to trans-
fection and cells in each well were transfected using
Lipofectamine2000 (Life Technologies) with 1 μg plasmid
for the WT or mutant hP2X7R and 0.1 μg plasmid for en-
hanced green fluorescent protein (GFP), according to the man-
ufacturer’s instructions.
Whole-cell patch-clamp current recording Cells were seed-
ed onto 10-mm glass coverslips 20–24 h post transfection and
single GFP-positive cells were chosen for recordings. Whole-
cell currents were recorded at room temperature using an
Axopatch 200B amplifier and analysed with pClamp 10.3
software (Axon instruments) as described in our previous
studies [31, 32]. Cells were kept at a holding potential of
−80 mV. BzATP and dithiothreitol (DTT) were applied using
a RSC-160 rapid solution changer (Biologic Science
Instruments). Patch microelectrodes with a resistance of 1–
5 MΩ were produced using borosilicate glass capillaries
(World Precision Instruments). Standard extracellular solution
contained: 147 mM NaCl, 2 mM KCl, 1 mM MgCl2, 2 mM
CaCl2, 10 mM HEPES and 13 mM glucose, pH 7.3.
Intracellular solution contained 145 mM NaCl, 10 mM
EDTA and 10 mM HEPES, pH 7.3. Divalent cations strongly
inhibit the P2X7R and therefore BzATP-induced currents
were mainly measured in low divalent extracellular solution
containing 147 mMNaCl, 2 mMKCl, 0.3 mMCaCl2, 10 mM
HEPES and 22 mM glucose, pH 7.3. Three hundred microm-
eter BzATP was repeated applied for 4 s every 2 min, and
when the currents were fully facilitated, cells were exposed
to 10 mM DTT between BzATP applications.
Data analysis All results, where appropriately, are presented
as the mean ± standard error of mean (SEM). Statistical anal-
ysis was carried out using Student’s t test for two groups and
one-way analysis of variance test and Tukey’s post hoc test for
more than two groups, and the difference was considered to be
significant at p < 0.05.
Results
Examination of the structural models of the hP2X7R in the
closed and open states suggests that considerable conforma-
tional changes take place during receptor activation in the
head, upper body and lower body of the extracellular domain
as well as in the TM α-helices. Such conformational changes
can be illustrated by the change in the distance, between the
K81 and V304 (K81/V304) residues located in the upper
body, I58/F311 and S60/L320 in the lower body, and A44/
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I331 and D48/I331 at the outer ends of the TM1 and TM2
domains (Fig. 1a, b). More specifically, these pairs of residues,
contributed from two adjacent subunits, are predicted to be in
the close vicinity to each other with the Cβ-Cβ distance in the
range of 4.9–6.2 Åwhen the receptor is in the closed state, and
move far apart, with the Cβ-Cβ distance increasing to 11.1–
14.8 Å during the transition from the closed to open state
(Fig. 1b). The I75/P177 in the head and from the same subunit
is also expected to undergo substantial change with the Cβ-
Cβ distance, changing from 9.1 Å in the closed state to 14.8 Å
in the open state (Fig. 1b). These pairs of positions, if replaced
with cysteines, may form disulphide bond in the closed state,
but the large distance between these positions in the open state
make the formation of disulphide bonds highly unlikely.
We introduced single and double cysteine substitutions into
these six pairs of residues and performed whole-cell patch-
clamp recordings to measure the currents in cells expressing
individual single and double mutants. Currents were evoked
Fig. 1 Location of residues in the hP2X7R targeted for cysteine
substitution. a Homology model of the hP2X7R with pairs of residues
that are subject to examination in this study coloured to correspond with
B. b Expanded views of the pairs of residues indicated in A with
sidechains indicated and distances between Cβ atoms of the identified
pairs in the closed and open states. The closed state is shown on the left
panel and the open state on the right. c Representative recording of
whole-cell currents induced by 300 μM BzATP from HEK293 cells
expressing the wild-type (WT) or indicated single mutant receptors. d
Summary of BzATP-induced current amplitude for the WT or single
mutant receptors. e Representative recording of whole-cell currents
induced by 300 μM BzATP from HEK293 cells expressing the WT or
indicated double mutant receptors. f Summary of BzATP-induced current
amplitude for the WTor double mutant receptors. *p < 0.05; **p < 0.01;
***p < 0.005 compared to the WT receptor. Three to six cells were
recorded in each case
Purinergic Signalling
by applying 300 μM BzATP, a super-maximal concentration
at the WT receptor [32]. The single mutants bearing D48C,
K81C or P177Cwere poorly functional, as evidenced by no or
very small BzATP-induced current in cells expressing them
(Fig. 1c, d). The other single mutants mediated noticeably
variable BzATP-induced current responses; A44C mutation
significantly increased, whereas L320C decreased, the ampli-
tude of BzATP-induced currents as compared to that mediated
by theWT receptor (Fig. 1c, d). In cells expressing the remain-
ing five mutants, the current amplitude was moderately re-
duced (I58C, I75C, V304C and F313C) or increased
(I331C), but the change was statistically insignificant. For
the six double mutants, only expression of the A44C/I331C
mutant led to considerable BzATP-induced currents and ex-
pression of the other double mutants gave rise to very small
but discernible BzATP-induced currents (Fig. 1e, f). None of
the single or double mutations altered the holding current.
We moved on to compare BzATP-induced currents in cell
expressing the WTor mutant receptor before and after expos-
ing the patched cells to DTT, a reducing agent. Exposure to
DTT for 10 min was without effect on the holding currents
(data not shown) and also had no effect on BzATP-induced
currents mediated by the WT receptor or single mutants
(Fig. 2a, b). Lack of significant effects of DTT on BzATP-
induced currents were also observed in cells expressing the
A44C/I331C double mutant or the poorly functional
I58C/F313C, S60C/L320C and I75C/P177C double mutants
(Fig. 2c, d). In striking contrast, treatment with DTT caused a
progressive and remarkable increase in small current BzATP-
induced currents in cells expressing the D48C/I331C double
mutant. The current amplitude in the steady state after DTT
treatment reached 64 ± 12% of that mediated by the WT
receptor (Fig. 2c). In addition, the effect of DTT on
D48C/I331C mutant-mediated currents was readily reversed
upon washing (Fig. 2c). Treatment with DTT also significant-
ly enhanced BzATP-induced currents in cells expressing the
K81C/V304C double mutant, albeit the current amplitude still
remaining much smaller relative to that mediated by the WT
receptor (Fig. 2c, d).
Discussion
As introduced above, the P2X7R is physiologically and ther-
apeutically important but our current understanding regarding
its activation and the conformational changes which accom-
modate this has been mainly inferred by structural homology
modelling and studies of single nucleotide polymorphic mu-
tations [27]. In this study, by combining cysteine-based cross-
linking with patch-clamp recording, we probed conformation-
al changes in the head, upper and lower body of the large
extracellular domain and the outer ends of the transmembrane
domains associated with hP2X7R activation. Specifically, we
examined six pairs of residues located in these parts which are
predicted by structural models to undergo considerable move-
ment during the transition of the ion channel from the closed
to open state (Fig. 1a, b). These 11 residues are present in
mammalian P2X7Rs but not conserved among the P2X recep-
tor family, with an exception of residues at three positions 75,
81 and 304 [1, 6, 27], andmany of them are also different from
those in the rP2X2R examined in a recent study [23]
(supplemental Fig. 1).
Introduction of single or double cysteine substitutions pre-
dominantly impaired or ablated receptor function (Fig. 1c, d).
Exposure to DTT did not rescue any single mutant with se-
verely impaired function (Fig. 2a, b). These results suggest
that cysteine substitution of the residues under investigation
introduced deficiencies in protein synthesis, membrane traf-
ficking, activation or a combination of these, which requires
further study for clarification. Such deficiencies are also likely
responsible for further loss of function in the double mutants
including I58C/F313C, S60C/L320C, I75C/P177C and
K81C/V304C. Notably, the amplitude of BzATP-induced cur-
rents mediated by the A44C/I331C double mutant was signif-
icantly reduced compared to that mediated by theWT receptor
(Fig. 1e, f). This result was not anticipated, considering that
the A44C and I331C mutations both individually increased
the current amplitude (Fig. 1d). The currents mediated by
the A44C/I331C double mutant were insensitive to DTT
(Fig. 2c, d), largely excluding the possibility that formation
of disulphide bond hinders the ion channel opening as
discussed further below. Currently, we cannot offer any
straightforward interpretation.
The most interesting finding in this study is the contrast in
results from the D48C/I331C and A44C/I331C double mu-
tants. BzATP induced very small but discernible currents in
cells expressing the D48C/I331C mutant (Fig. 1e, f).
However, BzATP-induced currents increased progressively
during treatment with DTT and in the steady state reached
Fig. 2 Effects of treatment with DTT on BzATP-induced currents
mediated by the WT and single and double cysteine mutant hP2X7Rs.
aRepresentative whole-cell recordings showing BzATP-induced currents
prior to, during and after exposure to 10 mM DTT in HEK293 cells
expressing the WT or indicated single mutant receptors. b Summary of
the effects of DTT treatment on the WT or single mutant receptors by
expressing BzATP-induced currents before and at the end of 10-min
exposure to DTT as percentage of the mean currents immediately before
exposure to DTT. The grey and black columns represent the mean
currents in percentage before and 10 min after DTT exposure,
respectively. c Representative whole-cell recordings showing BzATP-
induced currents prior to, during and after exposure to 10 mM DTT in
HEK293 cells expressing the WTor indicated double mutant receptors. d
Summary of the effects of DTT treatment on the WT or indicated mutant
receptors by expressing BzATP-induced currents at the end of 10-min
exposure to DTTas a percentage of the mean currents immediately before
exposure to DTT. The grey and black columns represent the mean
currents in percentage pre- and post-DTT application, respectively.
*p < 0.05. Three to six cells were recorded for each case
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more than half of that mediated by the WT receptor (Fig. 2c).
Furthermore, DTT-induced effect was readily reversed by
washing (Fig. 2c). These results were not observed for
BzATP-induced currents mediated by the single mutants
(Fig. 2a, b). The most plausible interpretation is that D48C
and I331C form an inter-subunit disulphide bond in the closed
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state and such cross-linking is sufficient to lock the receptor
ion channel in the closed state, as described in previous studies
for the rP2X2R and rP2X2/3R [16, 19, 23]. The Cβ-Cβ dis-
tance between D48 and I331 is 5.0 and 12.6 Å in the closed
and open states, respectively, suggesting that these two resi-
dues move a considerable distance from each other as the
hP2X7R ion channel switches from the closed to open state.
Our results clearly support the existence of such conforma-
tional changes at the outer ends of the TM helices. In contrast
with the D48C/I331C double mutant, expression of the
A44C/I331C double mutant resulted in considerable BzATP-
induced currents (Fig. 1e, f), and A44C/I331C mutant-
mediated currents were completely insensitive to DTT
(Fig. 2c). The Cβ-Cβ distance between A44 and I331 is pre-
dicted to be 5.8 Å in the closed state (Fig. 1b), which is similar
to that between D48 and I331. One possible explanation is
therefore that A44C and I331C form a disulphide bond but
the disulphide bond does not hinder receptor activation. This
explanation is clearly not appealing, because A44 and I331 are
predicted to fall 14.8 Å apart in the open state (Fig. 1b), which
is too great a distance to retain the disulphide bond between
A44C and I331C. A44 is located approximately one α-helix
underneath D48 in the TM1 domain (Fig. 1a). Such an expla-
nation is also hard to reconcile with the considerable confor-
mational change at the outer ends of the two TM domains as
indicated by the results from the D48C/ I331C double mutant.
An alternative, more likely, explanation is that A44C does not
form a disulphide bond with I331C. This explanation is more
consistent with the structural models, in which A44 is predict-
ed to be nestled more deeply in the TM1 domain and not well
positioned towards I331 (Fig. 1b). Overall, our results from
examining these two double mutants, particularly
D48C/I331C, provide clear evidence to support the conforma-
tional changes in the outer ends of the TM domains accompa-
nying hP2X7R activation.
The upper body, based on comparison of the zfP2X4R
structures in the closed and open states, remains much less
mobile than other parts of the extracellular domain during
receptor activation. In this study, we examined K81 and
V304 in the upper body of the hP2X7R which are predicted
to move significantly away from each other during receptor
activation (Fig. 1a, b). The K81C mutation impaired the re-
ceptor function (Fig. 1c, d), which also accounts for the poor
functional expression of the K81C/V304C double mutant
(Fig. 1e, f). Treatment with DTT had no effect on BzATP-
induced currents in cells expressing the K81C or V304C sin-
gle mutants (Fig. 2a, b), but significantly enhanced BzATP-
induced currents in cells expressing the K81C/V304C double
mutant, although the current remained very small (Fig. 2c, d).
These results suggest the formation of a disulphide bond be-
tween K81C and V304C in the receptors that were trafficked
to the cell surface. These results also support the increased
separation between K81 and V304 in the upper body
predicted by the structural models (Fig. 1b) when the receptor
switches from the closed to the open state.
In summary, our study provides evidence to support the
notion that conformational changes in the upper part of the
extracellular and the outer ends of the transmembrane do-
mains are crucial for hP2X7R activation.
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